Kerry Team Pushes to Build on Syria Disarmament Plan

Global Security Newswire Staff
See more stories about...
Global Security Newswire Staff
Sept. 12, 2013, 8:02 a.m.

De­vel­op­ing a thor­ough plan to elim­in­ate the Syr­i­an gov­ern­ment’s chem­ic­al arms is the fo­cus of arms-con­trol ex­perts ac­com­pa­ny­ing U.S. Sec­ret­ary of State John Kerry for talks sched­uled to start on Thursday with Rus­sia, Re­u­ters re­por­ted.

A high-level State De­part­ment in­sider said the two coun­tries were ex­pec­ted to ex­am­ine over­laps and dis­tinc­tions in their re­spect­ive in­tel­li­gence on Syr­ia’s “chem­ic­al weapons stock­piles,… pro­duc­tion fa­cil­it­ies, pre­curs­or chem­ic­als and [any] mu­ni­tions that are used to spread those chem­ic­al weapons,” the New York Times re­por­ted.

En­sur­ing the safety of any chem­ic­al-arms mon­it­ors in the war-torn Middle East­ern coun­try is one prac­tic­al con­sid­er­a­tion that ne­go­ti­at­ors would con­sider in Geneva, Switzer­land. Their dis­cus­sions might con­tin­ue through Sat­urday.

Mo­scow has sent Wash­ing­ton its pro­pos­al for hand­ling the weapons, the Lon­don Tele­graph said, cit­ing Rus­si­an press re­ports from Wed­nes­day.

A Rus­si­an dip­lo­mat­ic in­sider said the plan calls for Syr­ia ini­tially to ac­cede to an in­ter­na­tion­al chem­ic­al-weapons ban, the Rus­si­an news­pa­per Kom­mersant re­por­ted, ac­cord­ing to the Tele­graph. Dam­as­cus sub­sequently would dis­close its chem­ic­al-arms man­u­fac­tur­ing and hold­ing sites, which aud­it­ors then would vis­it, the source ad­ded. A deal would fol­low to es­tab­lish ex­act mech­an­isms for elim­in­at­ing the stocks, the un­named of­fi­cial said.

The Rus­si­an en­voy sug­ges­ted Wash­ing­ton and Mo­scow could jointly handle the Syr­i­an ar­sen­al un­der the aus­pices of the Nunn-Lugar Co­oper­at­ive Threat Re­duc­tion ini­ti­at­ive.

“We have seen more co­oper­a­tion and help­ful activ­ity on this mat­ter from the Rus­si­ans in the last two days than we’ve seen in the last two years,” White House spokes­man Jay Car­ney said in a Wed­nes­day press brief­ing. “The pro­pos­al they put for­ward is very spe­cif­ic; Syr­ia’s re­ac­tion to it changes the po­s­i­tion they’ve held for years and is a total about-face from the po­s­i­tion Bashar [As­sad] held three days ago. And that is sig­ni­fic­ant.”

What We're Following See More »
Monmouth Has Clinton Up Seven
2 minutes ago

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Clinton Advisers Talking to Psychologists, Trump Ghostwriter
20 minutes ago

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

Scientists Declare Dawn of Anthropocene Epoch
2 hours ago

"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."

House Committee Investigating Mylan
2 hours ago

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.